UCB stock gains on Alphavalue price target increase
Published on 09/15/2026 at 22:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UCB SA (ISIN BE0003739530) stock finished the September 14, 2026 session on Euronext Brussels at EUR 210.50, up about 2.4 percent from the prior close and standing out against a softer European market backdrop as Alphavalue raised its price target on the shares to EUR 249.
Analyst upgrade supports recent move
According to IT BOLTWISE, UCB shares closed at EUR 210.50 on Euronext Brussels on September 14, 2026, marking a daily gain of 2.38 percent and drawing attention among heavyweights in the Brussels market.
The same report cites Alphavalue, which confirmed its accumulate rating on UCB and lifted its price target to EUR 249 per share, implying a potential upside of roughly 18.3 percent from the September 14, 2026 closing level of EUR 210.50.IT BOLTWISE
Stock level in recent trading
In the Brussels market coverage referenced by IT BOLTWISE, UCB was highlighted as one of the stocks underpinning the local index performance as broader European indices turned lower, underlining the relative strength of UCB shares at the EUR 210.50 level on September 14, 2026.IT BOLTWISE
The latest available closing data thus puts UCB stock clearly below the new EUR 249 price target while still reflecting a firm tone in recent sessions, as investors reacted positively to the analyst reassessment.
Current price snapshot
Based on the most recent completed session, the reference price for UCB stock is the Euronext Brussels close of EUR 210.50 as of September 14, 2026, in euros as the home-market currency.
UCB stock key data
- Company: UCB SA
- ISIN: BE0003739530
- Ticker: UCB
- Trading venue: Euronext Brussels
- Price (as of September 14, 2026): 210.50 EUR
- Sector / Industry: Pharmaceuticals / Biotechnology
- Index membership: BEL 20
